AWSRX
Price
$18.00
Change
+$0.10 (+0.56%)
Updated
Jul 31 closing price
Net Assets
652.94M
RWIFX
Price
$80.99
Change
+$0.72 (+0.90%)
Updated
Jul 31 closing price
Net Assets
157.74B
Interact to see
Advertisement

AWSRX vs RWIFX

AWSRX vs RWIFX Comparison Chart in %
View a ticker or compare two or three
VS
AWSRX vs. RWIFX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWSRX is a Buy and RWIFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIFX has more cash in the bank: 158B vs. AWSRX (653M). RWIFX pays higher dividends than AWSRX: RWIFX (1.60) vs AWSRX (0.65). AWSRX was incepted earlier than RWIFX: AWSRX (15 years) vs RWIFX (24 years). AWSRX (1.50) is less costly to investors than RWIFX (0.46). AWSRX is a more actively managed with annual turnover of: 80.00 vs. RWIFX (44.00). RWIFX has a lower initial minimum investment than AWSRX: RWIFX (250) vs AWSRX (1000). RWIFX annual gain was more profitable for investors over the last year : 15.97 vs. AWSRX (7.60). RWIFX return over 5 years is better than : 34.86 vs. AWSRX (9.89).
AWSRXRWIFXAWSRX / RWIFX
Total Expense Ratio1.500.46326%
Annual Report Gross Expense Ratio1.500.46326%
Fund Existence15 years24 years-
Gain YTD10.76914.21576%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets653M158B0%
Annual Yield % from dividends0.651.6040%
Returns for 1 year7.6015.9748%
Returns for 3 years32.3245.4971%
Returns for 5 years9.8934.8628%
Returns for 10 years36.9096.9038%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EEMDX11.950.25
+2.14%
MFS Emerging Markets Equity Research R1
TISCX31.940.31
+0.98%
Nuveen Large Cap Responsible Eq R6
BDHIX9.040.08
+0.90%
BlackRock Dynamic High Income Instl
NSMVX46.11-0.15
-0.32%
North Star Micro Cap I
FNGAX16.92-0.17
-0.99%
Franklin Intl Growth A